ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Health Technology

Santen Pharmaceutical Co., Ltd.

Business Summary

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2022 JPYUSD
Revenue266,257M2,369.41M
Gross Profit146,852M1,306.83M
Operating income35,976M320.14M
Income before tax37,220M331.21M
Net income27,224M242.26M
EBITDA53,031M471.92M
Diluted EPS67.960.60
Dividends Per Share320.28
Total Assets459,976M3,789.70M
Total liabilities123,134M1,014.49M
Total equity337,488M2,780.53M
Operating cash flow46,043M409.73M
Currency in JPYCurrency in USD

Historical Data

 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 224,942M 234,026M 241,555M 249,605M 266,257M
Gross Profit 129,618M 134,165M 134,703M 140,734M 146,852M
Operating income 38,637M 41,242M 40,125M 37,068M 35,976M
Income before tax 39,261M 43,117M 32,091M 12,046M 37,220M
Net income 35,247M 31,953M 23,616M 9,315M 27,224M
EBITDA 49,533M 52,211M 56,698M 54,990M 53,031M
Diluted EPS 86.42 78.43 59.00 23.25 67.96
Dividends Per Share 26 26 27 28 32
Total Assets 388,463M 391,186M 408,768M 405,285M 459,976M
Total liabilities 100,904M 98,614M 106,208M 95,641M 123,134M
Total equity 285,823M 290,900M 302,865M 310,181M 337,488M
Operating cash flow 42,843M 32,894M 39,947M 38,808M 46,043M
 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 2,029.56M 2,110.34M 2,221.69M 2,353.48M 2,369.41M
Gross Profit 1,169.49M 1,209.84M 1,238.92M 1,326.96M 1,306.83M
Operating income 348.60M 371.90M 369.04M 349.50M 320.14M
Income before tax 354.23M 388.81M 295.15M 113.57M 331.21M
Net income 318.02M 288.13M 217.20M 87.82M 242.26M
EBITDA 446.91M 470.81M 521.47M 518.49M 471.92M
Diluted EPS 0.77 0.70 0.54 0.21 0.60
Dividends Per Share 0.23 0.23 0.24 0.26 0.28
Total Assets 3,652.68M 3,534.22M 3,786.46M 3,667.73M 3,789.70M
Total liabilities 948.79M 890.94M 983.81M 865.52M 1,014.49M
Total equity 2,687.56M 2,628.17M 2,805.47M 2,807.06M 2,780.53M
Operating cash flow 386.55M 296.62M 367.41M 365.91M 409.73M

Valuation Measures

Mar 2022
PER18.02
ROA6.29%
ROE8.40%
Operating margin13.51%
Profit margin10.22%

Key executives

  • President & Chief Executive Officer: Takeshi Ito
  • CFO, General Manager-Finance & Administration: Kazuo Koshiji
  • Chief Information Officer, GM-Digital & IT: Minori Hara
  • Chief Compliance Officer & Executive Officer: Mika Masunari
  • Executive Officer: Kenji Morishima

Shareholders

  • Black Creek Investment Management, Inc. (5.3%)
  • Nomura Asset Management Co., Ltd. (5.1%)
  • Massachusetts Financial Services Co. (4.3%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (3.6%)
  • Mitsubishi UFJ Financial Group, Inc. (3.6%)
  • MFS International (UK) Ltd. (2.9%)
  • Nikko Asset Management Co., Ltd. (2.8%)
  • Nippon Life Insurance Co. (2.7%)
  • The Vanguard Group, Inc. (2.3%)
  • SPARX Asset Management Co., Ltd. (2.0%)

Contact Details

  • Website:http://www.santen.co.jp
  • Address: Grand Front Osaka Tower A, 25/F, 4-20 Ofuka-cho, Osaka, 530-8552, Japan
  • Phone: +81.6.7664.8621

Related Companies

  • Chongqing Santen Kerui Pharmaceutical Co. Ltd.
  • Santen China Investment Co. Ltd.
  • Santen LLC
  • Santen Pharmaceutical Performance Share Unit
  • Santen Pharmaceutical (Hong Kong) Ltd.
  • Phacor, Inc.
  • Santen Canada, Inc.
  • Santen Pharmaceutical Restricted Stock Compensation Plan
  • Santen Philippines, Inc.
  • Santen Pharma Malaysia Sdn. Bhd.
  • Santen (Thailand) Co. Ltd.
  • Santen SA
  • Santen Eye Care Co., Ltd.
  • Santen Business Services Co. Ltd.
  • Claire Co. Ltd.
  • Santen Pharmaceutical Spain SL
  • SantenPharma AB
  • Santen India Pvt Ltd.
  • Santen Pharmaceutical Korea Co. Ltd.
  • Santen Pharmaceutical Asia Pte Ltd.
  • Santen Pharmaceutical Sales & Marketing (Suzhou) Co., Ltd.
  • Taiwan Santen Pharmaceutical Co. Ltd.
  • Santen SAS
  • Santen Pharmaceutical Trust
  • Santen Pharmaceutical (China) Co. Ltd.
  • Santen Holdings U.S., Inc.
  • Santen Pharmaceutical Pension Fund
  • Santen GmbH
  • Santen Oy
  • Santen Holdings EU BV

Competitors

  • Nicox SA
  • EyePoint Pharmaceuticals, Inc.
  • HLB Therapeutics Co., Ltd.
  • CHO Pharma, Inc.
  • Satellos Bioscience Inc
  • PharmaEssentia Corp.
Last Updated on 27 Jan, 2023

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more